Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 136 publications
Does robotics add value in Hartmann's reversal? A PRISMA-based systematic review and meta-analysis of perioperative outcomes.
Journal: Techniques in coloproctology
Published: March 07, 2026
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study.
Journal: Journal of neurology
Published: November 03, 2025
Long-term safety and efficacy of ponesimod, an oral S1P1 receptor modulator, in relapsing-remitting multiple sclerosis (RRMS): Results from randomized phase 2b core and extension studies spanning up to 13 years.
Journal: Multiple sclerosis and related disorders
Published: July 04, 2025
Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 16, 2025
Somatosensory Profile of Central Post Stroke Pain of Thalamic Origin: Findings of a Quantitative Sensory Testing Study.
Journal: European journal of pain (London, England)
Published: December 22, 2024
Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical trial.
Journal: Multiple sclerosis and related disorders
Published: November 28, 2024
Visual evoked potentials in multiple sclerosis: P100 latency and visual pathway damage including the lateral geniculate nucleus.
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Published: October 07, 2023
Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 29, 2023
Erratum to: Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis
Journal: Schmerz (Berlin, Germany)
Published: January 20, 2023
Erratum to: Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis
Journal: Der Nervenarzt
Published: January 16, 2023
Last Updated: 09/26/2026